Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galmed Pharmaceutica (NQ: GLMD )

0.4001 -0.0199 (-4.74%)
Streaming Delayed Price Updated: 3:01 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,557
Open 0.4000
Bid (Size) 0.4100 (1)
Ask (Size) 0.4250 (44)
Prev. Close 0.4200
Today's Range 0.3800 - 0.4251
52wk Range 0.2900 - 1.838
Shares Outstanding 25,088,414
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive... 
Via Benzinga
Why Tuesday Morning Shares Are Trading Lower By 38%; Here Are 31 Stocks Moving Premarket
Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 106.9% to $0.5482 in pre-market trading on heavy volume. 
Via Benzinga

Performance

YTD
-43.75%
-43.75%
1 Month
-25.77%
-25.77%
3 Month
-25.89%
-25.89%
6 Month
+21.24%
+21.24%
1 Year
-73.33%
-73.33%

More News

Read More
Galmed's Aramchol Shows Anti-Fibrotic Effects In Lung Fibrosis Animal Model
Via Benzinga
Recap: Galmed Pharmaceuticals Q4 Earnings
Via Benzinga
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Galmed Pharmaceuticals: Q2 Earnings Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
Galmed Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
Raymond James Maintains Outperform Rating for Galmed Pharmaceuticals: Here's What You Need To Know
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022
Via Benzinga
Galmed Pharmaceuticals's Earnings Outlook
Via Benzinga
Galmed Pharmaceuticals Q4 2021 Earnings Conference Call On May 2, 2022 At 08:30 AM ET
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
66 Biggest Movers From Yesterday
Via Benzinga
25 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For May 2, 2022
Via Benzinga
Galmed's Potential Ulcerative Colitis Candidate Shows Encouraging Action In Early Study
Via Benzinga
Galmed's NASH Candidate Shows Clinically Significant Effect On Fibrosis Improvement
Via Benzinga
26 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
Galmed Reveals Early Aramchol Data From Late-Stage NASH Trial
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.